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Abstract
Background: With the increasing amount of data generated in molecular genetics laboratories, it
is often difficult to make sense of results because of the vast number of different outcomes or
variables studied. Examples include expression levels for large numbers of genes and haplotypes at
large numbers of loci. It is then natural to group observations into smaller numbers of classes that
allow for an easier overview and interpretation of the data. This grouping is often carried out in
multiple steps with the aid of hierarchical cluster analysis, each step leading to a smaller number of
classes by combining similar observations or classes. At each step, either implicitly or explicitly,
researchers tend to interpret results and eventually focus on that set of classes providing the "best"
(most significant) result. While this approach makes sense, the overall statistical significance of the
experiment must include the clustering process, which modifies the grouping structure of the data
and often removes variation.
Results:  For hierarchically clustered data, we propose considering the strongest result or,
equivalently, the smallest p-value as the experiment-wise statistic of interest and evaluating its
significance level for a global assessment of statistical significance. We apply our approach to
datasets from haplotype association and microarray expression studies where hierarchical
clustering has been used.
Conclusion: In all of the cases we examine, we find that relying on one set of classes in the course
of clustering leads to significance levels that are too small when compared with the significance level
associated with an overall statistic that incorporates the process of clustering. In other words,
relying on one step of clustering may furnish a formally significant result while the overall
experiment is not significant.
Background
Hierarchical clustering is an information theoretical
method that sequentially merges samples based on the
pair-wise similarity of a given measurement to form com-
mon groups until all samples are contained in a single
group [1]. The method has many applications and is
widely used in the analysis of biological data. For exam-
ple, researchers testing for association between haplotypes
and disease have employed hierarchical clustering as a
means to reduce a large number of haplotypes to a man-
ageable number of haplotype classes with the aim to
increase statistical power [2]. The alleles present at multi-
ple genetic marker loci across a given chromosome form a
haplotype [3]. With an increasing number of marker loci,
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the number of possible haplotypes grows exponentially so
that many of these haplotypes tend to have low frequency.
In comparisons of haplotype frequencies between case
and control individuals, the corresponding contingency
tables are often sparse and difficult to interpret. Hierarchi-
cal clustering then allows researchers to merge haplotypes
into classes that are easier to handle. Variability within a
haplotype class is generally considered unimportant (ran-
dom noise) so that the researcher can focus on the "larger
picture", that is, whether some of the haplotype classes
exhibit a statistically significant difference in frequency
between case and control individuals. Typically, the statis-
tical significance (computed with exact tests [4]) for an
initial, sparse contingency table is lower than for tables
obtained by clustering the haplotype classes present in the
initial table. Often the process of clustering incorrectly
removes the variation within a class, and in these cases the
increase in statistical significance is entirely due to the
clustering process. Here we propose an analysis method
that properly takes clustering into account. We achieve
this by defining the strongest result or, equivalently, the
smallest p-value, occurring in the course of clustering as
the statistic of interest and computing its associated
(experiment-wise) statistical significance.
Another example of hierarchical clustering is its applica-
tion in microarray analyses [5-7]. Often clustering of
arrays based on microarray expression data is utilized to
distinguish tumor subclasses, which have clinical implica-
tions [8,9]. In many of these studies involving microarray
expression data from tumor specimens, researchers are
interested in examining survival information for the sub-
jects who contributed the samples and comparing the sur-
vival curves between groups formed by the hierarchical
clustering procedure [10-13]. The methods developed in
this paper will be applied to three previously published
datasets in which hierarchical clustering has been
employed. One of these datasets involves a haplotype
association analysis while the other two datasets refer to
survival analyses of groups of individuals determined by
microarray expression measurements.
The problem of testing group differences sequentially is in
the framework of multiple testing. Historically, both
genetic association studies and microarray studies have
been plagued with multiple testing problems. In the case
of association studies, multiple testing occurs because
researchers perform tests of association for large numbers
of haplotypes, alleles, or genotypes across entire chromo-
somes or genomes [14]. In the case of microarray data
analysis, researchers sequentially test thousands of genes
for differential expression. Testing at each different clus-
tering step within a hierarchical structure also represents a
form of multiple comparisons; therefore, the experiment-
wise type I error is inflated. Various correction methods
such as Bonferroni, step-up, and step-down have been
employed to adjust for the multiplicity of testing [15].
These procedures appear to work well only when the tests
in the sequence are independent or weakly correlated.
Since the tests within the hierarchy possess a nested struc-
ture, these procedures are inappropriate for our situation.
As mentioned above, here we propose an alternative solu-
tion by defining a single test statistic, for which we evalu-
ate the experiment-wise statistical significance.
Methods
Local p-values
Consider multiple steps in hierarchical clustering. For
each of n steps of the hierarchy, we calculate our statistic
of interest depending on the application. In the case of
haplotype association tests, we compute the Pearson χ2
[4] for a 2 × s contingency table (case/control individuals
versus s haplotypes or haplotype classes) while in the case
of survival analyses, we compute the log-rank statistic
[16]. We represent these statistics as a vector,
, where Xi  represents the statistic
obtained at the ith step in the clustering process. To make
statistics from different steps comparable, we compute the
significance level, pi, associated with Xi and call this a local
p-value. We approximate these local empirical signifi-
cance levels via permutation analysis. These permutation
methods involve randomly permuting labels for each
individual as follows. For haplotype association tests, we
permute the case/control labels [17,18] while for survival
analyses, we permute failure times and censorship sta-
tuses jointly. For each permutation of the dataset, we clus-
ter the permuted samples as illustrated by the dendrogram
and calculate a null statistic based on the permuted sam-
ples at each step in order to generate the null distribution
for the statistic. We can represent the collection of null sta-
tistics calculated from each of m permutations of the data
at each of n steps within the hierarchy as the matrix,
where the entry appearing in the ith row and the jth col-
umn, Xij, is the statistic of interest computed from the ith
permutation of the data at the jth step in the hierarchy. At
each step of the hierarchy, by comparing the statistic we
computed from the data with the null statistics we com-
puted from the m permutations, we calculate a local p-
value, pj, as the proportion of permutation samples with a
null statistic at least as large as the observed statistic. We
represent the local p-values as the vector,
.
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Permutation (randomization) samples allow one to con-
veniently approximate the sampling distribution of test
statistics under the null hypothesis (the "null distribu-
tion"). Ideally, permutation tests are based on the total of
all permutations but in practice we usually can only col-
lect a random sample from these permutations. The
number  m  of permutation samples should be large
enough to adequately represent the sample space of per-
mutations. For the haplotype data (example 1), at each
step we compared approximated p-values obtained with
different values of m with exact p-values calculated with
the aid of the statistical software package StatXact 5. For
the first few steps in the hierarchy, values of m on the
order of 10,000 were sufficient to provide p-values very
close to the correct ones. However, at later steps, agree-
ment was only obtained with m = 100,000, presumably
because at early steps the total number of permutations is
much smaller than at later steps. The calculations for the
two survival analyses (examples 2 and 3) were also per-
formed with m = 100,000.
Global p-value
In order to gain an empirical significance assessment for
the entire experiment, we define a single statistic, that is,
the smallest of the local p-values, mini(pi) [19]. To assess
the empirical significance level (global p-value), pmin, asso-
ciated with this statistic, we generate the null distribution
of mini(pi)from the matrix of null statistics, Xnull. In this
matrix, we consider each row (replicate) in turn as
observed data and evaluate these data based on the
remaining m - 1 null data as described above for m null
data. That is, for each of these "null observed" permuta-
tion samples a minimum p-value is obtained at whatever
step it occurs. This leads to a set of m  null values for
mini(pi). The proportion of these values at least as small as
the observed mini(pi)represents the global significance
level, pmin, associated with our single experiment-wise sta-
tistic. Since this approach requires that the p-values be
ordered, starting with the most significant, it could be
considered a step-down p-value adjustment procedure
similar to the procedure developed by Westfall and Young
[20]. If pmin ≤ 0.05 then we say that the experiment (at least
one of the steps in the clustering process) is significant at
the 5% level.
In addition, we are interested in assessing whether cluster-
ing has provided a benefit for the data analysis. In order
to achieve this, we compare the statistical significance for
the entire experiment involving tests at each step created
by clustering with the statistical significance for an exper-
iment where no clustering has been applied; that is, we
compare the global p-value,  pmin, with the significance
level, p0, of the statistic prior to clustering. (We are able to
make this exact comparison for the haplotype association
application; however, for the microarray expression stud-
ies, we must compare the global significance with the sta-
tistical significance at step 2 in the hierarchy since
permuting the data at steps 0 and 1 creates a collection of
null statistics possessing a very small variance.) Clustering
is only beneficial when pmin <p0 (or p2 for the microarray
datasets) since the results are more significant when clus-
tering is applied. It may well happen that the smallest p-
value, mini(pi), at one of the steps in the course of cluster-
ing is smaller than p0 (or p2 for the microarray datasets),
but the clustering process is such that this smallest p-value
has a high probability of occurring by chance. In that case,
one will find that pmin  >p0  (or  p2  for the microarray
datasets).
Statistics of interest
As mentioned above, in the case of association studies
between haplotypes and disease we employ the Pearson
χ2 to test each step of the hierarchy for association [4].
However, in the case of survival analyses, our statistic of
interest is the log-rank statistic [16]. It provides an overall
comparison of the Kaplan-Meier survival curves for two or
more groups of subjects. For r groups, the log-rank statistic
asymptotically follows a χ2 distribution with r - 1 degrees
of freedom under the null hypothesis of equality of sur-
vival curves.
Results
To demonstrate our approach on real data, we re-analyze
the following three previously published datasets.
Example 1 (haplotype data)
The first dataset consists of 52 statistically predicted hap-
lotypes in 172 African-American study participants (137
case and 35 control individuals) [2]. The aim of that case-
control study was to test for association between haplo-
types at 25 single nucleotide polymorphism (SNP) loci in
the human µ opioid receptor gene (OPRM1) and sub-
stance dependence. The large number of haplotypes was
difficult to interpret and appeared to create a situation
with insufficient power to detect association. Thus, hierar-
chical clustering was applied to the 52 haplotypes. These
were sequentially grouped according to the procedure
CLUSTER (method = BAVERAGE, measure = SEUCLID)
from the SPSS software package for Windows [2]. For each
step of the resulting dendrogram, the hierarchical cluster-
ing procedure designates which haplotypes are clustered
to form haplotype classes. At each step of the hierarchy an
association test was performed between haplotype classes
and disease status. As the clustering progressed, the
number of classes became smaller and smaller.
Using the same clustering methods and resulting hierar-
chical structure, we apply our algorithm for assessing local
and global p-values in this dataset. Our p-values differ
somewhat from the ones previously published [2] but theBMC Bioinformatics 2003, 4 http://www.biomedcentral.com/1471-2105/4/62
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patterns of the local p-values across the clustering steps
shown in Figure 1 and in [2], respectively, are highly com-
parable. Based on m = 100,000 permutation samples (see
Methods), we calculate local p-values for hierarchical clus-
tering steps zero through 20, where zero represents the
step with un-clustered haplotypes and 20 represents the
step where only two haplotype groups remain. We find
the smallest p-value, mini(pi)= 0.0561, at step 14 (Figure
1). Thus, one is tempted to declare this result borderline
significant at the 5% level. However, the (global) signifi-
cance level associated with this smallest p-value turns out
to be pmin = 0.6918; that is, there is almost a 70% random
chance (unrelated to association between haplotypes and
disease) to find at any step in the hierarchy a minimum p-
value at least as small as the value of 0.0561 found for the
observed data. This sobering result leaves the experiment
statistically non-significant. Since clustering failed to pro-
duce an experiment-wise significance level of pmin less than
the initial pre-clustering significance level of p0 = 0.5263,
the clustering process did not provide any benefit for this
dataset.
Example 2 (lung cancer data)
This dataset contains expression levels for 835 unique
genes represented by 918 cDNA clones in tissues har-
vested from lung cancer patients and normal individuals
[11]. Specifically, expression levels are measured in 41
adenocarcinomas (ACs), 16 squamous cell carcinomas
(SCCs), five large cell lung cancers (LCLCs), five small cell
lung cancers (SCLCs), five normal lung samples, and one
normal fetal lung sample. Based on the Complete Linkage
method and Pearson's correlation coefficient as a measure
of similarity in the CLUSTER software, hierarchical cluster
analysis was performed to group the samples according to
the degree of similarity present in the gene expression
data. In the resulting dendrogram, the AC samples
appeared in three distinct clusters. The aim of the study
was to examine whether the groups of AC samples created
by the hierarchical clustering procedure correlated with
clinical outcomes of the AC patients, that is, whether the
Kaplan-Meier survival curves differed for these groups
[11].
Again, using the same clustering methodology as in the
publication [11], we apply this technique to their AC data
[21] and work with the resulting hierarchical structure for
assessing the local and global p-values. The dendrogram
in Figure 2A details the hierarchical clustering of the data
(for the 24 AC samples from patients with reported sur-
vival information) for steps zero through 22. For each step
in the hierarchy we calculate a log-rank statistic and the
corresponding local p-value (m = 100,000 permutation
Results from haplotype association tests applied to all steps of the hierarchical structure formed by clustering data from Hoehe  et al. [2] Figure 1
Results from haplotype association tests applied to all steps of the hierarchical structure formed by clustering data from Hoehe 
et al. [2]. This bar graph presents the local p-values computed by our group at all steps within the hierarchical structure.BMC Bioinformatics 2003, 4 http://www.biomedcentral.com/1471-2105/4/62
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samples). Figure 2B graphically presents these local p-val-
ues. We exclude the first two clustering steps (0 and 1)
from the figure and further assessments because insuffi-
cient variability in the log-rank statistic at these steps does
not permit meaningful calculation of local p-values. At
step 22, we observe the minimum local p-value of 0.0002,
and we calculate the global p-value for this dataset to be
0.0040. Thus, the experiment shows a statistically signifi-
Results from log-rank tests applied to steps of the hierarchical structure formed by clustering data from Garber et al. [11] Figure 2
Results from log-rank tests applied to steps of the hierarchical structure formed by clustering data from Garber et al. [11]. A, 
This schematized dendrogram reflects the process of clustering microarray samples according to the similarity of their gene 
expression profiles as measured by the Pearson correlation coefficient. Distances between array sample clusters are approxi-
mated (not to scale) by the vertical axis. Along the bottom of the dendrogram are the microarray tissue samples from individ-
uals for which survival data was available [11]. B, This bar graph displays the local p-values we compute at each step within the 
structure created by hierarchical clustering.BMC Bioinformatics 2003, 4 http://www.biomedcentral.com/1471-2105/4/62
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cant result, and clustering was effective. It reduced the ini-
tial p-value of 0.0321 at step 2 to the global significance
level of pmin = 0.0040.
Example 3 (lymphoma data)
The third dataset contains expression levels of cDNA
clones from genes expressed in germinal center B-cells for
47 samples of diffuse large B-cell lymphoma (DLBCL)
[12]. Hierarchical clustering was performed with the
CLUSTER program and the Pearson correlation coefficient
as its similarity measure to group the samples by similar-
ity of gene expression levels for all genes expressed in ger-
minal center B-cells. The resulting dendrogram shows two
main branches, one containing samples with expression
patterns similar to those of germinal center B-cells and
one containing samples with expression patterns similar
to those of activated B-cells. To examine the clinical rele-
vance of this subdivision of DLBCL, a Kaplan-Meier sur-
vival analysis for the two groups of patients was
performed based on the dendrogram's penultimate clus-
tering step [12].
As with the other datasets, we cluster the data [22] with
the same method as published [12] and use the resulting
hierarchical structure for calculations of log-rank statistics
and associated local p-values (m = 100,000 permutation
samples) at different steps in the hierarchy. The dendro-
gram in Figure 3A provides the order of clustering (for the
40 DLBCL samples from patients with reported survival
information) for steps zero through 38 while Figure 3B
graphically presents local p-values at the different cluster-
ing steps. As in example 2, we observe a very small vari-
ance in the log-rank statistic at the first two clustering
steps and, therefore, exclude these steps from further anal-
ysis. At step 6, we observe the minimum local p-value of
0.0010, with an associated global p-value of pmin = 0.0364.
This result is statistically significant at the 5% level, but
clustering has not contributed to an increase in signifi-
cance because un-clustered or only minimally clustered
data show higher significance (lower p-value). These are
not mutually exclusive ideas. The implication is that if
clustering is applied, the result of testing over the entire
hierarchy is significant; however, the results would be
more significant had the experimenter never clustered the
data in the first place.
Discussion
In hierarchical clustering, evaluating the minimum local
p-value in isolation, outside of the context of the larger
hierarchical structure used to organize the data, can dras-
tically affect the interpretation of test results. For example,
even though the haplotype data show an apparently sig-
nificant result with a minimum p-value of 0.0561, our
analysis demonstrates that clustering the same data but
without association between haplotypes and disease has a
high chance of obtaining such a "significant" result. In
fact, that chance is pmin = 0.6918, which represents the
actual significance level of the experiment. On the other
hand, as example 2 shows, clustering can improve the sig-
nificance of a result. The global significance level, pmin, can
be viewed as a version of mini(pi) corrected for multiple
testing within the hierarchy. In all three examples pre-
sented above, applying the Bonferroni correction to
mini(pi) provides an upper bound for pmin in agreement
with theory. In fact, it is interesting that for examples 2
and 3 our procedure which accounts for the correlated
nature of the tests yields a pmin value only slightly smaller
than the Bonferroni correction applied to mini(pi).
How can we explain that in some cases clustering is bene-
ficial while in other cases it is not? Presumably, some
datasets possess an underlying heterogeneity; that is, such
datasets are composed of samples from multiple distinct
populations. If the information used for clustering (hap-
lotypes for example 1 and gene expression patterns for
examples 2 and 3) is related to the information used to
perform the statistical test (in our examples, proportions
of cases to controls and survival times), hierarchical clus-
tering will detect the heterogeneity. Otherwise, the cluster-
ing process is random, and any heterogeneity detected is
artificial. Our approach allows one to distinguish between
these two situations. If the clustering process is random
because the information used for clustering and calculat-
ing the test statistic are unrelated (or because the dataset is
homogeneous), a large pmin will result indicating that any
small local p-values probably occurred only by chance.
Whereas if the clustering process is directed by a measure-
ment strongly related to the test statistic, a small pmin will
result indicating that any heterogeneity found within the
hierarchy is most likely real.
Often when hierarchical clustering is applied to a dataset,
it is of interest to determine the true number of classes
present. This situation commonly arises in the analysis of
microarray data. For instance, as in examples 2 and 3, in
the study of human cancers, researchers often utilize
microarray expression data to cluster samples. From the
hierarchical structure created by clustering, it may be of
interest to distinguish the optimum number of tumor
subclasses that are most clinically relevant. Several statis-
tics-based methods have been utilized to estimate the true
number of groups from such microarray expression data-
sets [23,24]. However, such methods rely solely on the
expression data itself. Alternatively, it may prove practical
in such microarray expression studies to consider addi-
tional information available, such as survival data, on
each sample for distinguishing clinically relevant sub-
classes. Employing our procedure of calculating the local
p-values for a test statistic at multiple steps within the hier-
archy and then selecting the step where the minimum ofBMC Bioinformatics 2003, 4 http://www.biomedcentral.com/1471-2105/4/62
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these p-values occurs as the basis for determining the true
number of classes which exist for a given dataset may pro-
vide an advantage over existing methods. Of course, if
such a method for determining the true number of classes
is applied, the global p-value will provide an assessment
of its significance. However, applying our procedure to
some datasets, such as the data in example 3, results in
determining a large number of true classes. In fact, the
number of classes determined may be so large that the use
of these expression-based tumor subclasses in clinical
diagnosis may not provide a benefit. Therefore, in order to
increase the practicality of our method, it may prove nec-
essary to eliminate some of the lower steps in the hierar-
chy from eligibility for selecting the minimum local p-
value and the calculation of its significance.
Besides determining subclasses for biological samples,
hierarchical clustering is often employed in the context of
microarray expression studies in order to identify groups
of genes that are regulated in a similar manner. In these
Results from log-rank tests applied to steps of the hierarchical structure formed by clustering data from Alizadeh et al. [12] Figure 3
Results from log-rank tests applied to steps of the hierarchical structure formed by clustering data from Alizadeh et al. [12]. A, 
This schematized dendrogram reflects the process of clustering microarray samples according to the similarity of their gene 
expression profiles as measured by the Pearson correlation coefficient. Distances between array sample clusters are approxi-
mated (not to scale) by the vertical axis. Along the bottom of the dendrogram are the microarray tissue samples from individ-
uals for which survival data was available [12]. B, This bar graph displays the local p-values we compute at each step within the 
structure created by hierarchical clustering.BMC Bioinformatics 2003, 4 http://www.biomedcentral.com/1471-2105/4/62
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cases, the clustering is performed on the genes rather than
on the samples. Our method relies on two sets of data –
one for clustering and a second for the statistical test.
Since the samples possess both expression data across
genes and survival data, our method is applicable to hier-
archies created by clustering on samples. However, genes
only possess expression data across samples, and, conse-
quently, our method is inappropriate for analyzing the
significance of hierarchies created by clustering on genes.
Our approach may be viewed as a contribution to the
problem of multiple testing. We address this problem by
defining a single experiment-wise statistic whose associ-
ated empirical significance level represents the overall sig-
nificance of the experiment. For the cases we have
examined, the experiment refers to performing a test at
each step in a hierarchy created by clustering. However,
the meaning of experiment can be expanded to reflect
other practices adopted by researchers. For example,
researchers may apply several clustering algorithms
involving various combinations of clustering methods
and distance measures before finalizing their choice of
clustering algorithm. Since this practice introduces an
additional test at each step within each of the trial hierar-
chies, it compounds the effect of multiple testing. Addi-
tionally, in some situations researchers may be interested
in testing for heterogeneity among groups with multiple
measurements. For instance, when searching for clinically
relevant subclasses of cancer, researchers may examine
groups for differences in survival times, as well as, differ-
ences in physical characteristics of the tumor cells. Both
sets of information may be clinically relevant; however, to
correct for the additional testing, the meaning of experi-
ment in calculating pmin must be expanded to reflect the
entire process employed by the researcher. Of course, it is
possible that the process of hierarchical clustering forms
medically relevant groups that do not display heterogene-
ity for any of the measurements collected. In this case, our
strategy will not find these groups as the true grouping
structure for the samples.
Several other methods addressing multiple comparison
problems have been proposed and are in current use. In
particular, as an alternative to the classical significance
level, p, the False Discovery Rate (FDR) has become rather
popular [15]. However, it is important to keep in mind
that p and FDR are not really comparable – p is the condi-
tional probability of a significant test result given the null
hypothesis is true (the expected proportion of false posi-
tive results among all "false" results, i.e., results obtained
under the null hypothesis) while FDR is the conditional
probability of the null hypothesis being true given a sig-
nificant test result (the expected proportion of false posi-
tive results among all "positive" results, i.e., significant
test results). Future research will have to determine which
of these various approaches to eliminate the effects of
multiple testing is most effective.
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